Copyright Reports & Markets. All rights reserved.

Global Neuroprotection Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Neuroprotection Market Overview

      • 1.1 Product Overview and Scope of Neuroprotection
      • 1.2 Neuroprotection Segment by Type
        • 1.2.1 Global Neuroprotection Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Free Radical Trapping Agents (Antioxidants)
        • 1.2.3 Glutamate Antagonists (Anti-Excitotoxic Agents)
        • 1.2.4 Apoptosis Inhibitors
        • 1.2.5 Anti-inflammatory Agents
        • 1.2.6 Neurotrophic Factors (NTFs)
        • 1.2.7 Metal Ion Chelators
        • 1.2.8 Stimulants
        • 1.2.9 Others
      • 1.3 Neuroprotection Segment by Application
        • 1.3.1 Neuroprotection Consumption Comparison by Application (2014-2025)
        • 1.3.2 Prevention
        • 1.3.3 Treatment
      • 1.3 Global Neuroprotection Market by Region
        • 1.3.1 Global Neuroprotection Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Neuroprotection Market Size
        • 1.4.1 Global Neuroprotection Revenue (2014-2025)
        • 1.4.2 Global Neuroprotection Production (2014-2025)

      2 Global Neuroprotection Market Competition by Manufacturers

      • 2.1 Global Neuroprotection Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Neuroprotection Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Neuroprotection Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Neuroprotection Production Sites, Area Served, Product Types
      • 2.5 Neuroprotection Market Competitive Situation and Trends
        • 2.5.1 Neuroprotection Market Concentration Rate
        • 2.5.2 Neuroprotection Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Neuroprotection Production Market Share by Regions

      • 3.1 Global Neuroprotection Production Market Share by Regions
      • 3.2 Global Neuroprotection Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Neuroprotection Production
        • 3.4.1 North America Neuroprotection Production Growth Rate (2014-2019)
        • 3.4.2 North America Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Neuroprotection Production
        • 3.5.1 Europe Neuroprotection Production Growth Rate (2014-2019)
        • 3.5.2 Europe Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Neuroprotection Production (2014-2019)
        • 3.6.1 China Neuroprotection Production Growth Rate (2014-2019)
        • 3.6.2 China Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Neuroprotection Production (2014-2019)
        • 3.7.1 Japan Neuroprotection Production Growth Rate (2014-2019)
        • 3.7.2 Japan Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Neuroprotection Consumption by Regions

      • 4.1 Global Neuroprotection Consumption by Regions
      • 4.2 North America Neuroprotection Consumption (2014-2019)
      • 4.3 Europe Neuroprotection Consumption (2014-2019)
      • 4.4 China Neuroprotection Consumption (2014-2019)
      • 4.5 Japan Neuroprotection Consumption (2014-2019)

      5 Global Neuroprotection Production, Revenue, Price Trend by Type

      • 5.1 Global Neuroprotection Production Market Share by Type (2014-2019)
      • 5.2 Global Neuroprotection Revenue Market Share by Type (2014-2019)
      • 5.3 Global Neuroprotection Price by Type (2014-2019)
      • 5.4 Global Neuroprotection Production Growth by Type (2014-2019)

      6 Global Neuroprotection Market Analysis by Applications

      • 6.1 Global Neuroprotection Consumption Market Share by Application (2014-2019)
      • 6.2 Global Neuroprotection Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Neuroprotection Business

      • 7.1 Daiichi Sankyo Company
        • 7.1.1 Daiichi Sankyo Company Neuroprotection Production Sites and Area Served
        • 7.1.2 Neuroprotection Product Introduction, Application and Specification
        • 7.1.3 Daiichi Sankyo Company Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Eli Lilly and Company
        • 7.2.1 Eli Lilly and Company Neuroprotection Production Sites and Area Served
        • 7.2.2 Neuroprotection Product Introduction, Application and Specification
        • 7.2.3 Eli Lilly and Company Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Allergan
        • 7.3.1 Allergan Neuroprotection Production Sites and Area Served
        • 7.3.2 Neuroprotection Product Introduction, Application and Specification
        • 7.3.3 Allergan Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Dr. Reddy’s Laboratories
        • 7.4.1 Dr. Reddy’s Laboratories Neuroprotection Production Sites and Area Served
        • 7.4.2 Neuroprotection Product Introduction, Application and Specification
        • 7.4.3 Dr. Reddy’s Laboratories Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Teva Pharmaceutical
        • 7.5.1 Teva Pharmaceutical Neuroprotection Production Sites and Area Served
        • 7.5.2 Neuroprotection Product Introduction, Application and Specification
        • 7.5.3 Teva Pharmaceutical Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis
        • 7.6.1 Novartis Neuroprotection Production Sites and Area Served
        • 7.6.2 Neuroprotection Product Introduction, Application and Specification
        • 7.6.3 Novartis Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 AstraZeneca
        • 7.7.1 AstraZeneca Neuroprotection Production Sites and Area Served
        • 7.7.2 Neuroprotection Product Introduction, Application and Specification
        • 7.7.3 AstraZeneca Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Astrocyte Pharmaceuticals
        • 7.8.1 Astrocyte Pharmaceuticals Neuroprotection Production Sites and Area Served
        • 7.8.2 Neuroprotection Product Introduction, Application and Specification
        • 7.8.3 Astrocyte Pharmaceuticals Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 F. Hoffmann-La Roche
        • 7.9.1 F. Hoffmann-La Roche Neuroprotection Production Sites and Area Served
        • 7.9.2 Neuroprotection Product Introduction, Application and Specification
        • 7.9.3 F. Hoffmann-La Roche Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Biogen
        • 7.10.1 Biogen Neuroprotection Production Sites and Area Served
        • 7.10.2 Neuroprotection Product Introduction, Application and Specification
        • 7.10.3 Biogen Neuroprotection Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Neuroprotection Manufacturing Cost Analysis

      • 8.1 Neuroprotection Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Neuroprotection
      • 8.4 Neuroprotection Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Neuroprotection Distributors List
      • 9.3 Neuroprotection Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Neuroprotection Market Forecast

      • 11.1 Global Neuroprotection Production, Revenue Forecast
        • 11.1.1 Global Neuroprotection Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Neuroprotection Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Neuroprotection Price and Trend Forecast (2019-2025)
      • 11.2 Global Neuroprotection Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Neuroprotection Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Neuroprotection Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Neuroprotection Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Neuroprotection Production, Revenue Forecast (2019-2025)
      • 11.3 Global Neuroprotection Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Neuroprotection Consumption Forecast (2019-2025)
        • 11.3.2 Europe Neuroprotection Consumption Forecast (2019-2025)
        • 11.3.3 China Neuroprotection Consumption Forecast (2019-2025)
        • 11.3.4 Japan Neuroprotection Consumption Forecast (2019-2025)
      • 11.4 Global Neuroprotection Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Neuroprotection Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Neuroprotection market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Neuroprotection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neuroprotection market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Daiichi Sankyo Company
        Eli Lilly and Company
        Allergan
        Dr. Reddy’s Laboratories
        Teva Pharmaceutical
        Novartis
        AstraZeneca
        Astrocyte Pharmaceuticals
        F. Hoffmann-La Roche
        Biogen

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Free Radical Trapping Agents (Antioxidants)
        Glutamate Antagonists (Anti-Excitotoxic Agents)
        Apoptosis Inhibitors
        Anti-inflammatory Agents
        Neurotrophic Factors (NTFs)
        Metal Ion Chelators
        Stimulants
        Others

        Segment by Application
        Prevention
        Treatment

        Buy now